Paclitaxel as an anticancer agent: Isolation, activity, synthesis and stability

Central European Journal of Medicine

Volumn 6, Issue 5, 2011, Pages 527-536

  Nikolic, Vesna D ^a   Savic, Ivan M ^a   Savic, Ivana M ^a   Nikolic, Ljubisa B ^a   Stankovic, Mihajlo Z ^a   Marinkovic, Valentina D ^b  

^a UNIVERSITY OF NI   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Activity; Complexation; Isolation; Paclitaxel; Synthesis

Indexed keywords

CREMOPHOR; CYCLODEXTRIN; MACROGOL; NANOPARTICLE; PACLITAXEL; VERAPAMIL;

ANTINEOPLASTIC ACTIVITY; APPETITE DISORDER; ARM PAIN; ARTHRALGIA; ARTICLE; BARK; BLEEDING; BREAST CANCER; BRITTLED HAIR; CHILL; COUGHING; CYTOTOXICITY TEST; DEFECATION HABIT; DIZZINESS; DRUG DEGRADATION; DRUG ERUPTION; DRUG FEVER; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG ISOLATION; DRUG PURIFICATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DYSPHAGIA; DYSPNEA; EXHAUSTION; FACIAL FLUSHING; FEMALE INFERTILITY; FLUSHING; HAND TINGLING; HUMAN; LEG PAIN; NAIL COLOR; NAUSEA AND VOMITING; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; SKIN BRUISING; SORE THROAT; STRUCTURE ACTIVITY RELATION; TASTE; TAXUS BACCATA; THORAX PAIN; TOE TINGLING;

EID: 81355161459     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-011-0074-5     Document Type: Article

References (69)

1. Rowinsky E.K., Donehower R.C., Paclitaxel (taxol). N. Engl. J. Med., 1995, 332, 1004-1014
2. Wani M.C., Taylor H.L., Wall M.E., Coggan P., McPhail A.T., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J. Am. Chem. Soc., 1971, 93, 2325-2327
3. Schiff PB, Fant J, Horwitz SB; Promotion of microtubule assembly in vitro by taxol. Nature 1979;(227):665-667 (Pubitemid 9114288)
4. Schiff P.B., Horwitz S.B., Taxol stabilizes microtubules in mouse fibroblast cells, PNAS 1980, 77, 1561-1565 (Pubitemid 10073801)
5. Rowinsky E.K., Cazenave L.A., Donehower R.C., Taxol: a novel investigational antimicrotubule agent, J. Natl. Cancer I 1990, 82, 1247-1259 (Pubitemid 20239995)
6. Stierle A., Strobel G., Stierle D., Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew, Science 1993, 260, 214-216 (Pubitemid 23140886)
7. Guo B.H., Kai G.Y., Jin H.B., Tang K.X., Taxol synthesis. Afr. J. Biotechnol. 2006, 5(1), 15-20
8. Strobel G., Yang X.S., Sears J., Kramer R., Sidhu R.S., Hess W.M., Taxol from Pestalotiopsis microspora, an endophytic fungus of Taxus wallachiana, Microbiology 1996, 142, 435-440 (Pubitemid 26068509)
9. Li J.Y., Stroble G., Sidhu R., Hess W.M., Ford E.J., Endophytic Taxolproducing fungi from bald cypress. Taxodium distichum, Microbiology 1996, 142, 2223-2226 (Pubitemid 26288098)
10. Wang J.F., Li G.L., Lu H.Y., Zheng Z.H., Huang Y.J., Su W.J., Taxol from Tubercularia sp. strain TF5, an endophytic fungus of Taxus mairei, FEMS Microbiol. Lett. 2000, 193, 249-253
11. U. Breme, M. Caruso, N.C. Perellino, L. Fedeli, A. Pavesi, L. Piacenza, G. Ventrella, 2003. Paclitaxel production by Actinomycetes. U.S. patent 6,528,301
12. Adler L.M., Herzog T.J., Williams S., Rader J.S., Mutch D.G., Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines, Cancer 1994, 74, 1891-1898 (Pubitemid 24301850)
13. Richheimer S.L., Tinnermeier D.M., Timmons D.W., High-performance liquid chromatographic assay of taxol, Anal. Chem. 1992, 64(20), 2323-2326.
14. Vyas D.M., Kadow J.F., Paclitaxel: A Unique Tubulin Interacting Anticancer Agent, Progr. Med. Chem. 1995, 32, 289-337
15. Xu Q., Trissel L.A., Martinez J.F., Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 °C, Am. J. Hosp. Pharm. 1994, 51, 3058-3060
16. T.B. Khac, M. Potier, 2004. Process for isolation and purification of paclitaxel from natural sources. U.S. patent 6,759,539
17. S.S.K. Foo, Y. Bai, M. Ehlert, 2000. Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material. U.S. patent 6,136,989
18. Kawamura F, Kikuchi Y, Ohira T, Yatagai M. Accelerated Solvent Extraction of Paclitaxel and Related Compounds from the Bark of Taxus cuspidate. J. Nat. Prod. 1999, 62(2), 244-247 (Pubitemid 29137898)
19. Zu Y., Wang Y., Fu Y., Li S., Sun R., Liu W., Luo H., Enzyme-assisted extraction of paclitaxel and related taxanes from needles of Taxus chinensis, Sep. Purif. Technol. 2009, 68(2), 238-243
20. P. Vemishetti, F.S. Gibson, J.L. Dillon, 2001. Semisynthesis of paclitaxel using dialkyildichlorosilanes. U.S. patent 6,242,614 B1
21. Denis J.N., Greene A.E., Guenard D., Voegelein F.G., Potier L.M.P., Highly efficient, practical approach to natural taxol, J. Am. Chem. Soc. 1988, 110(17), 5917-5919
22. R.A. Holton, 1993. Metal alkoxides. U.S. patent 5,274,124
23. M.A. Poss, J.L. Moniot, I.D. Trifunovich, D.J. Kucera, J.K. Thottathil, S.H. Chen, J. Wei, 1994. Novel sidechain-bearing taxanes and intermediates thereof. W.O. patent 9414787
24. Kingston D.G.I., Chaudhary A.G., Gunatilaka A.A.L., Middleton M.L., Tetrahedron. Lett. 1994, 35, 4483-4484
25. Commerçon A., Bézard D., Bernard F., Bourzat J.D., Improved protection and esterification of a precursor of the taxotere® and taxol side chains, Tetrahedron. Lett. 1992, 33(36), 5185-5188
26. Holton R.A., Somoza C., Kim H.B., Liang F., Biediger R.J., Boatman P.D., Shindo M., Smith C.C., Kim S., Nadizadeh H., Suzuki Y., Tao C., Yu P., Tang S., Zhang P., Murthi K.K., Gentile L.N., Liu J.H., First total synthesis of Taxol, J. Am. Chem. Soc. 1994, 116, 1597-1600
27. Nicolaou K.C., Yang Z., Liu J.J., Ueno H., Nantermet P.G., Guy R.K., Claiborne C.F., Renaud J., Couladouros E.A., Paulvannan K., Sorensen E.J., Total synthesis of Taxol, Nature 1994, 367, 630-634 (Pubitemid 24069071)
28. Danishefsky S.J., Master J.J., Young W.B., Link J.T., Snyder L.B., Magee T.V., Jung D.K., Isaacs R.C.A., Bornmann W.G., Alaimo C.A., Coburn C.A., Di Grandi M.J., Total Synthesis of Baccatin III and Taxol, J. Am. Chem. Soc. 1996, 118, 2843-2859 (Pubitemid 126661137)
29. Morihira K., Hara R., Kawahara S., Nishimori T., Nakamura N., Kusama H., Kuwajima I., Enantio-selective total synthesis of Taxol, J. Am. Chem. Soc. 1998, 120, 12980-12981
30. Nikolic V., Stankovic M., Kapor A., Nikolic Lj., Cvetkovic D., Stamenkovic J., Allylthiosulfinate:β-Cyclodextrin Inclusion Complex: Preparation, Characterization and Microbiological Activity, Die Pharmazie 2004, 59(11), 845-848 (Pubitemid 39524581)
31. Nikolic V., Nikolic Lj., Stankovic M., Kapor A., Popsavin M., Cvetkovic D., A molecular inclusion complex of atenolol with 2-hydroxypropyl-β- cyclodextrin; production and characterization thereof, J. Serb. Chem.Soc. 2007, 72(8-9), 737-746
32. Nikolic V., Ilic D., Nikolic Lj., Stankovic M., Cakic M, Stanojevic Lj., Kapor A., Popsavin M., The protection of Nifedipin from photodegradation due to complex formation with β-cyclodextrin, Cent. Eur. J. Chem. 2010, 8(4), 744-749
33. Savic I., Nikolic G., Savic I., Cakic M., Studies of the forced hydrolysis degradation of copper complexes with different oligosaccharides, Russ. J. Phys. Chem. A 2010, 84(13), 2306-2313
34. Savic I., Nikolic G., Savic I., Cakic M., Conductometric studies on the stability of copper complexes with different oligosaccharides, Cent. Eur. J. Chem. 2010, 8(5), 1078-1085
35. Sharma U.S., Balasubramanian S.V., Straubinger R.M., Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins, J. Pharm. Sci. 1995,84(10), 1223-1230
36. Hamada H., Ishihara K., Masuoka N., Mikuni K., Nakajima N., Enhancement of Water-Solubility and Bioactivity of Paclitaxel using Modified Cyclodextrins, J. Biosci. Bioeng. 2006, 102(4), 369-371 (Pubitemid 44781320)
37. Dordunoo S.K., Burt H.M., Solubility and stability of paclitaxel: effects of buffers and cyclodextrins, Int. J. Pharm. 1996, 133, 191-201 (Pubitemid 26163334)
38. R.Yong, G. Jianfeng, Y. Shuqin, W. Ling, 2009. Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof. Eu patent 075010
39. Lee S.C., Huh K.M., Lee J., Cho Y.W., Galinsky R.E., Park K., Hydrotropic Polymeric Micelles for Enhanced Paclitaxel Solubility: In Vitro and In Vivo Characterization, Biomacromolecules 2007, 8(1), 202-208
40. Ma G., Yang J., Zhang L., Song C., Effective antitumor activity of paclitaxel-loaded poly (ε-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model, Anti-cancer drugs 2010, 21(3), 261-269
41. Oh K.S., Song J.Y., Cho S.H., Lee B.S., Kim S.Y., Kim K., Jeon H., Kwon I.C., Yuk S.H., Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy, J. Control. Releas. 2010; doi:10.1016/j.jconrel.2010.08.021
42. C. Mahesh, W. Jane, R.E. Barrett, 2005. Method for preparing submicron particles of paclitaxel. W.O. patent 0466712005
43. Tomas E., Karel U., Blanka R., Milada S., Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates, Molecules 2008, 13, 360-378
44. Leonelli F., Bella A.L., Migneco L.M., Bettolo R.M., Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates, Molecules 2008, 13, 360-378
45. B. Martin, C. Ladisav, S. Roman, S. Pavel, 2006. Process for the isolation of paclitaxel. W.O. patent 014356
46. K.V. Rao, 1995. Method for the isolation and purification of taxol and its natural analogues. U.S. patent 5,475,120
47. Rao K.V., Taxol and related taxanes. I. Taxanes of Taxus brevifolia bark, Pharm. Res. 1993, 10(4), 521-524 (Pubitemid 23113042)
48. Wall M.E., Wani M.C., Camptothecin and Taxol: Discovery to Clinic-Thirteenth Bruce F. Cain Memorial Award Lecture, Cancer Rese. 1995, 55, 753-760
49. Carlier M.F., Pantaloni D., Taxol Effect on Tubulin Polymerization and Associated Guanosinev 5'-Triphosphate Hydrolysis, Biochemistry 1983, 22, 4814-4822 (Pubitemid 13016997)
50. Schiff P.B., Fant J., Horwitz S.B., Promotion of microtubule assembly in vitro by taxol, Nature 1979, 277(5698), 665-667 (Pubitemid 9114288)
51. Georg G.I., Boge T.C., Cheruvallath Z.S., Clowers S.J., Harriman G.C.B., Hepperle M., Park H., The medical chemistry of taxol. In: Suffness M (ed.), Taxol science and applications. , Boca Raton: CRC Press, 1995, pp. 317-375
52. Nicolaou K.C., Dai W.M., Guy R.K., Chemistry and biology of taxol, Angew. Chem. Int. Edit. 1994, 33, 15-44 (Pubitemid 24986738)
53. Han Y., Chaudhary A.G., Chordia M.D., Sackett D.L., Ramirez B.P., Kingston D.G.I., Bane S., Interaction of a Fluorescent Derivative of Paclitaxel (Taxol) with Microtubules and Tubulin-Colchicine, Biochemistry 1996, 35, 14173-14183 (Pubitemid 26384413)
54. Horwitz S.B., Mechanizam of action of Taxol, Trends Pharmacol. Sci. 1992, 13(4), 134-136
55. Suffness M., Taxol: From Discovery to Therapeutic Use, Ann. Rep. Med. Chem. 1993, 28, 305-314
56. Horwitz S.B., Cohen D., Rao S., Ringel I., Shen H.J., Yang C.P., Taxol: mechanisms of action and resistance, J. Nati. Cancer I 1993, 15, 55-61
57. Kingston D.G.I., Taxane Anticancer Agents, Chapter 15. USA: American Chemical Society, 1995
58. Rowinsky E.K., Cazenave L.A., Donehower R.C., Taxol: a novel investigational antimicrotubule agent, J. Nati. Cancer I 1990, 82(15), 1247-1259 (Pubitemid 20239995)
59. Kant J., The Chemistry and Pharmacology of Taxol and Its Derivatives, 5 ed. New York, Pharmochemistry Library, Elsevier, 1995
60. Boge T.C., Himes R.H., Velde D.G.V., Georg G.I., The effect of the aromatic rings of taxol on biological activity and solution conformation: synthesis and evaluation of saturated taxol and taxotere analogues, J. Med. Chem. 1994, 37(20), 3337-3343 (Pubitemid 24325047)
61. Rowinsky E.K., Donehower R.C., The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics, Pharmacol. Therapeut. 1991, 52(1), 35-84
62. Schiff P.B., Horwitz S.B., Taxol stabilizes microtubules in mouse fibroblast cells, PNAS 1980, 77(3), 1561-1565 (Pubitemid 10073801)
63. Ding A.H., Porteu F., Sanchez E., Nathan C.F., Shared actions of endotoxin and taxol on TNF receptors and TNF release, Science 1990, 248(4953), 370-372
64. Manthey C.L., Brandes M.E., Perera P.Y., Vogel S.N., Taxol increases steady-state levels of lipopolysaccharide- inducible genes and protein-tyrosine phosphorylation in murine macrophages, J. Immunol. 1992, 149(7), 2459-2465
65. Ozcelik B., Turkyilmaz C., Ozgun M.T., Serin I.S., Batukan C., Ozdamar S., Ozturk A. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist. Fertil. Steril. 93(5), 1609-1614
66. Sznitowska M., Klunder M., Placzek M., Paclitaxel Solubility in Aqueous Dispersions and Mixed Micellar Solutions of Lecithin, Chem. Pharm. Bull. 2008, 56(1), 70-74
67. Kim S.C., Jaewon Y., Lee J.W., Seok P.E., Cheol C.S., Sensitive HPLC method for quantitation of paclitaxel (Genexol®) in biological samples with application to preclinical pharmacokinetics and biodistribution, J. Pharmaceut. Biomed. 2005, 39(1-2), 170-176
68. Haruo Y., Mihoko N., Mitsuhiro W., Ken'ichiro N., Simultaneous HPLC determination of paclitaxel and verapamil in rat plasma, Chromatography 2005, 26(2), 49-50
69. Baldrey S.F., Brodie R.R., Morris G.R., Jenkins E.H., Brookes S.T., Comparison of LC-UV and LCMS- MS for the Determination of Taxol, Chromatographia, 2005, 55, S-187 - S-192